Albert David Limited share price

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, and vision care products. The company exports its products to Latin American, South East Asian and North African countries Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.Read more

Website NSE हिंदी में BSE

HealthcareDrug Manufacturers - Specialty & GenericNSE: ALBERTDAVDISIN INE155C01010

16 Oct 2026, 3:29 PM IST₹831.00▲ 40.30 (5.10%)

Market Cap₹ 474 Cr.
Current Price₹ 831.00
High / Low₹ 932 / 580
Stock P/E21.0
Book Value₹ 686
Dividend Yield0.63 %
ROCE0.8 %
ROE-0.40 %
Face Value₹ 10.0

More figures (10)

EPS (TTM)₹ 39.53
Price / Book1.21
OPM0.0 %
Debt / Equity0.08
Sales growth (5Y)6.2 %
Profit growth (5Y)—
Promoter holding64.0 %
EV / EBITDA9.2
Beta0.35
All-time high₹ 1,754

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
ALBERTDAVD	-3.42%	+19.71%	+14.90%	+12.82%	+4.66%	-0.77%	+5.62%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Albert David Limited is in the Drug Manufacturers - Specialty & Generic industry (Healthcare), with a market value of ₹474 crore.
It trades at 21.0 times its last 12 months' earnings and 1.2 times book value.
Revenue grew 6.2% a year over the last 5 years.
Return on equity was -0.4% and return on capital employed 0.8% in the latest year.
Debt was 0.08 times shareholders' equity.
The share price is 10.8% below its 52-week high and up 4.7% over one year.
Promoters and insiders hold about 64.0%; institutions about 1.6%.

Pros

Company is almost debt-free (debt is 0.08 times equity).
Latest quarter (Jun 2026): sales up 44% and profit up 303% from a year ago.
Promoters hold a large stake of 62.24%.

Cons

Return on equity has been low: 8.6% on average over the last 3 years.
Other income makes up 48% of profit before tax.
Trades at 21.0 times earnings, above its 3-year median of 17.0.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Albert David Limited

Employees: 1,476
Head office: Kolkata

HealthcareDrug Manufacturers - Specialty & Generic

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Albert David	831.00	21.0	474	0.63	32	303.12	101	43.60	0.8	-0.4	1.21	0.0	0.08	64.04	334	6.2
2.	Sun Pharmaceutical Industries	1,758.80	34.9	4,21,995	0.91	2,895	34.65	15,184	18.48	17.9	14.7	5.05	23.4	0.06	55.61	58,220	10.4
3.	Divi's Laboratories	9,144.50	83.0	2,42,758	0.33	902	36.25	3,080	19.15	19.0	16.2	14.48	28.4	0.00	52.00	10,476	11.0
4.	Torrent Pharmaceuticals	4,558.90	72.8	1,73,406	0.83	566	3.28	4,921	54.85	9.1	27.1	18.39	25.0	1.79	63.18	13,980	13.3
5.	Zydus Lifesciences	1,123.00	25.0	1,12,020	0.09	940	-19.74	7,802	24.03	19.0	19.7	4.17	21.7	0.46	75.18	26,720	16.5
6.	Laurus Labs	2,060.10	101.8	1,11,310	0.12	362	123.94	2,026	29.10	19.5	18.2	20.98	19.4	0.48	32.03	6,813	3.8
7.	Cipla	1,325.10	31.8	1,07,051	0.98	789	-35.42	7,077	7.26	14.9	11.8	3.11	17.5	0.02	31.13	27,712	7.2
8.	Dr. Reddy's Laboratories	1,233.00	31.0	1,02,707	0.66	444	-68.72	8,071	-5.56	14.2	12.1	2.68	14.9	0.21	30.14	33,593	11.0
9.	Aurobindo Pharma	1,666.90	26.0	95,910	0.00	1,033	14.29	9,106	8.65	13.5	9.9	2.56	15.6	0.21	54.79	33,385	10.7
10.	Mankind Pharma	2,275.50	46.0	93,988	0.00	568	35.00	4,031	30.89	13.7	12.5	5.76	19.9	0.39	75.39	14,278	17.7
	Median: 37 Co.	1,712.85	31.4	26,200	0.33	679	24.47	5,999	21.59	14.6	16.8	4.93	17.0	0.21	55.20	20,499	13.4

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Standalone figures in ₹ crore

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	92	93	88	89	89	98	83	75	71	87	90	86	101
YOY Sales Growth %	-1.34%	0.86%	18.39%	9.38%	-2.82%	5.64%	-5.89%	-15.90%	-21.03%	-11.37%	8.24%	14.65%	43.60%
	79	77	80	79	88	92	82	80	81	85	79	83	91
Material Cost %	34%	34%	37%	33%	34%	31%	32%	39%	36%	35%	31%	35%	36%
Employee Cost %	24%	22%	26%	26%	32%	30%	34%	30%	40%	31%	27%	27%	25%
Other Expenses %	27%	27%	27%	30%	33%	33%	33%	37%	39%	31%	30%	35%	29%
Operating Profit	13	16	8	10	1	6	1	-5	-11	3	11	3	11
OPM %	14%	17%	9%	11%	1%	6%	1%	-6%	-15%	3%	12%	3%	10%
Other Income	18	12	17	10	23	21	-9	-5	22	-2	12	-25	28
Interest	0	0	0	0	0	0	0	0	1	1	1	0	1
Depreciation	2	1	2	2	2	2	2	2	2	2	2	3	2
Profit before tax	29	27	23	18	22	25	-10	-12	8	-3	20	-25	36
	20%	24%	20%	29%	15%	28%			6%		23%		11%
Current tax	4	5	4	3	1	2	1	2			3	0	1
Deferred tax	1	1	1	3	2	5	-2	-3	1	1	1	-4	3
	23	20	19	13	19	18	-9	-10	8	-3	15	-21	32
YOY Profit Growth %	1,238.15%	0.80%	77.48%	245.74%	-19.78%	-10.97%	-150.15%	-179.98%	-57.88%	-118.27%			303.12%
EPS in Rs	41.16	35.57	32.80	22.63	33.02	31.67	-16.45	-18.10	13.91	-5.79	26.81	-37.56	56.07
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Standalone figures in ₹ crore

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	73	73	317	321	247	314	342	362	346	334	364
YOY Sales Growth %			335.05%	1.23%	-22.86%	26.70%	8.95%	6.12%	-4.61%	-3.52%
	64	64	287	290	228	273	297	316	343	328	338
Material Cost %	24%	24%	34%	33%	35%	37%	36%	35%	34%	34%	34%
Employee Cost %	29%	29%	28%	28%	33%	27%	24%	24%	32%	31%	27%
Other Expenses %	35%	35%	29%	30%	24%	23%	27%	28%	34%	34%	31%
Operating Profit	8	8	30	30	19	41	44	47	3	5	27
OPM %	12%	12%	9%	9%	8%	13%	13%	13%	1%	2%	7%
Other Income	3	3	7	7	17	16	15	58	30	7	13
Interest	0	0	1	1	1	1	0	0	0	3	3
Depreciation	1	1	7	8	8	9	9	7	7	10	10
Profit before tax	10	10	29	29	27	47	51	97	25	1	28
	30%	30%	39%	34%	19%	25%	29%	22%	32%	385%	19%
Current tax	3	3	11	11	4	13	16	16	6	3
Deferred tax	0	0	-0	-1	1	-1	-1	6	2	-1
	7	7	27	19	22	35	36	75	17	-1	23
YOY Profit Growth %			302.39%	-28.05%	15.52%	59.23%	2.60%	108.49%	-77.19%	-108.69%
EPS in Rs	11.60	11.60	46.68	33.59	38.80	61.78	63.39	132.15	30.14	-2.62	39.53
Dividend Payout %							14%	7%	38%

Compounded Sales Growth

5 Years:: 6%
3 Years:: -1%
TTM:: 11%

Compounded Profit Growth

TTM:: 259%

Stock Price CAGR

5 Years:: 6%
3 Years:: -1%
1 Year:: 5%

Return on Equity

4 Years:: 9%
Last Year:: 0%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	6	6	6
Reserves	306	377	387	386
	5	3	12	30
Short term borrowings	4	2	10	28
	107	112	107	98
Trade payables	32	34	38	33
Current liabilities	99	99	104	115
Total Liabilities	423	498	511	519
	83	89	100	121
Gross block	224	234	250	278
Accumulated depreciation	140	145	150	157
Goodwill & intangibles	2	2	1	1
CWIP	9	11	6	26
	331	399	406	372
Inventories	51	44	64	58
Trade receivables	30	29	27	34
Cash & equivalents	1	5	0	0
Current assets	304	372	354	374
Total Assets	423	498	511	519

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	11	46	-28	-8
Profit for the year	36	75	17	-1
Working capital changes	-26	9	-29	-15
Direct taxes paid	-16	-16	-9	-5
	-5	-33	23	-4
Fixed assets purchased	-5	-11	-15	-29
Fixed assets sold	0	0	0	0
Investments purchased	-6	-41
Investments sold	8	8	34	18
	-6	-8	0	12
Proceeds from borrowings	0
Interest paid	-0	-0	-0	-2
Dividends paid	-5	-5	-7	-3
Net Cash Flow	-1	4	-5	-0
Free Cash Flow	5	35	-43	-37

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	11.6%	21.7%	4.4%	-0.4%
ROCE	—	15.7%	24.4%	6.3%	0.8%
Operating margin	—	10.7%	11.4%	-0.8%	0.0%
Net margin	—	10.6%	20.9%	5.0%	-0.5%
Debt / equity	—	0.02	0.01	0.03	0.08
Current ratio	—	3.08	3.75	3.40	3.24
Debtor days	—	33	30	29	38
Inventory days	—	147	124	197	184
Days payable	—	93	96	116	102
Cash conversion cycle	—	87	58	110	120
Working capital days	—	220	276	266	287

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 62.24%
FIIs 0.60%
DIIs 1.64%
Public 35.53%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	62.04%	62.13%	62.13%	62.13%	62.13%	62.24%	62.24%	62.24%	62.24%	62.24%	62.24%	62.24%
	0.70%	0.98%	0.80%	0.88%	0.86%	1.01%	0.84%	0.60%	0.60%	0.58%	0.57%	0.60%
Foreign portfolio investors (Cat. I)	0.70%	0.98%	0.80%	0.87%	0.85%	0.97%	0.83%	0.60%	0.60%	0.58%	0.57%	0.52%
Foreign portfolio investors (Cat. II)				0.01%	0.01%	0.03%	0.01%					0.08%
	1.67%	1.67%	1.67%	1.64%	1.64%	1.65%	1.66%	1.66%	1.66%	1.66%	1.64%	1.64%
Mutual funds	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Insurance companies	1.65%	1.65%	1.65%	1.61%	1.61%	1.61%	1.61%	1.61%	1.61%	1.61%	1.61%	1.61%
Banks	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Alternative investment funds						0.01%	0.02%	0.02%	0.02%	0.02%
	35.59%	35.22%	35.40%	35.35%	35.37%	35.11%	35.26%	35.50%	35.50%	35.52%	35.56%	35.53%
Retail (up to ₹2 lakh)	24.86%	24.70%	24.79%	24.93%	26.13%	25.67%	26.16%	26.07%	25.32%	25.01%	25.31%	25.56%
HNIs (above ₹2 lakh)	2.63%	2.02%	2.48%	2.70%	1.80%	1.76%	1.65%	1.65%	2.05%	2.44%	2.74%	2.36%
NRIs	0.71%	0.85%	0.80%	1.02%	1.02%	0.90%	0.88%	0.92%	0.94%	0.96%	0.99%	0.90%
Bodies corporate	4.64%	4.31%	3.78%	3.22%	2.95%	3.01%	1.86%	2.18%	2.52%	2.44%		1.96%
IEPF	0.71%	0.71%	0.71%	0.70%	0.75%	0.75%	0.75%	0.74%	0.81%	0.80%	0.80%	0.80%
No. of Shareholders	10,041	11,266	12,349	13,590	14,830	15,304	15,070	14,666	13,967	13,555	13,155	12,709

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Albert David

Holder (above 1%)	Stake
General Insurance Corporation Of IndiaInsurance	1.61%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 0.01% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

None filed recently.

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 30 Jul 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

No recent coverage found.

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Albert David Limited

What is the share price of Albert David Limited today?

Albert David Limited (ALBERTDAVD) last traded at ₹831.00 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of Albert David Limited?

About ₹474 crore at the latest price.

What is the P/E ratio of Albert David Limited?

About 21.0 times its earnings over the last 12 months.

Is Albert David Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Albert David Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.